Skip to main content
. 2023 May 11;12(11):1738–1750. doi: 10.1002/psp4.12976

FIGURE 3.

FIGURE 3

Comparison of simulated Kaplan–Meier curves of progression‐free survival (PFS) and overall survival (OS) between dose groups (1200 mg q2w vs. 500 mg q2w). Kaplan–Meier plot of expected PFS and OS for virtual patients with second‐line non‐small cell lung cancer receiving 500 mg (red) or 1200 mg (blue) every 2 weeks (q2w) of bintrafusp alfa. The solid lines represent the median and the shaded areas are 90% simulation interval from 500 simulated trials.